{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:14Z","timestamp":1788922154628,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA041359"],"award-info":[{"award-number":["R01DA041359"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA056581"],"award-info":[{"award-number":["R01DA056581"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA013429"],"award-info":[{"award-number":["P30DA013429"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neulet.2025.138154","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:00:36Z","timestamp":1738954836000},"page":"138154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Deletion of \u03b2-arrestin 2 in mice affects kappa opioid receptor-mediated behaviors depending on sex, ovariectomy status, and behavioral endpoints"],"prefix":"10.1016","volume":"850","author":[{"given":"Peng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad K.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Bland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Yuan","family":"Liu-Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2025.138154_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2025.138154_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)33422-1","article-title":"U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist","volume":"224","author":"von Voigtlander","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2025.138154_b0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-6147(86)90257-9","article-title":"In-vivo studies on kappa opioid receptors","volume":"7","author":"Cowan","year":"1986","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.neulet.2025.138154_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/164_2020_420","article-title":"Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans","volume":"271","author":"Inan","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neulet.2025.138154_b0025","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0024-3205(01)00957-2","article-title":"The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice","volume":"68","author":"Tsuji","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.neulet.2025.138154_b0030","doi-asserted-by":"crossref","unstructured":"E.A. Townsend, J.E. Naylor, S.S. Negus, S.R. Edwards, H.N. Qureshi, H.W. McLendon, C.R. McCurdy, C.N. Kapanda, J.M. do Carmo, F.S. da Silva, J.E. Hall, K.J. Sufka, K.B. Freeman, Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats, Psychopharmacology (Berl) 234 (2017) 2597-2605. https:\/\/doi.org\/10.1007\/s00213-017-4652-3.","DOI":"10.1007\/s00213-017-4652-3"},{"key":"10.1016\/j.neulet.2025.138154_b0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.118.255661","article-title":"Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine","volume":"371","author":"Kaski","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2025.138154_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108244","article-title":"Nalfurafine modulates the reinforcing effects of oxycodone in male and female adolescent C57BL\/6J mice","volume":"176","author":"Zhang","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/FBP.0000000000000581","article-title":"The kappa-opioid receptor agonist, nalfurafine, blocks acquisition of oxycodone self-administration and oxycodone's conditioned rewarding effects in male rats","volume":"31","author":"Zamarripa","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neulet.2025.138154_b0050","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00213-020-05473-4","article-title":"Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys","volume":"237","author":"Zamarripa","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-002-1028-z","article-title":"Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats","volume":"161","author":"Mori","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1196\/annals.1316.050","article-title":"Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence","volume":"1025","author":"Hasebe","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neulet.2025.138154_b0065","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00213-020-05543-7","article-title":"Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice","volume":"237","author":"Dunn","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837671","article-title":"The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies","volume":"13","author":"Dalefield","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neulet.2025.138154_b0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00192549","article-title":"The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist","volume":"46","author":"Rimoy","year":"1994","journal-title":"Eur. J. Clin. Pharmacol"},{"key":"10.1016\/j.neulet.2025.138154_b0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00002826-199619050-00009","article-title":"Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain","volume":"19","author":"Pande","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neulet.2025.138154_b0085","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.neulet.2025.138154_b0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/164_2020_400","article-title":"Clinical Profiles of Nalfurafine Hydrochloride for the Treatment of Pruritus Patients","volume":"271","author":"Miyamoto","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neulet.2025.138154_b0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neulet.2025.138154_b0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14656566.2020.1849142","article-title":"An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease","volume":"22","author":"Lipman","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.neulet.2025.138154_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108860","article-title":"Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects","volume":"202","author":"Huang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0110","first-page":"303","article-title":"Description of Ovariectomy Protocol in Mice","volume":"2019","author":"Souza","year":"1916","journal-title":"MethodsMol Biol"},{"key":"10.1016\/j.neulet.2025.138154_b0115","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot094474","article-title":"Determining the Stage of the Estrous Cycle in Female Mice by Vaginal Smear","volume":"2016","author":"Gonzalez","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.neulet.2025.138154_b0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.physbeh.2009.11.003","article-title":"Estrous cycle in ob\/ob and ovariectomized female mice and its relation with estrogen and leptin","volume":"99","author":"Ng","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neulet.2025.138154_b0125","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41386-018-0155-0","article-title":"Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in kappa opioid aversion, Neuropsychopharmacology : official publication of the American College of","volume":"44","author":"Liu","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.123.001870","article-title":"NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties","volume":"389","author":"Huang","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2025.138154_b0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.104.073668","article-title":"Comparison of pharmacological activities of three distinct k ligands (Salvinorin A, TRK-820 and 3FLB) on k opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo","volume":"312","author":"Wang","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2025.138154_b0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2003.09.057","article-title":"Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions","volume":"995","author":"Suzuki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2025.138154_b0145","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.drugalcdep.2013.08.021","article-title":"L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors","volume":"133","author":"Xu","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2025.138154_b0150","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuropharm.2015.08.027","article-title":"Investigation of the role of betaarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus","volume":"99","author":"Morgenweck","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/jpet.114.216820","article-title":"The G protein-biased kappa-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo","volume":"352","author":"White","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2025.138154_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173377","article-title":"Sex- and beta-arrestin-dependent effects of kappa opioid receptor-mediated ethanol consumption","volume":"216","author":"French","year":"2022","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neulet.2025.138154_b0165","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp6038","article-title":"Kappa opioids inhibit spinal output neurons to suppress itch","volume":"10","author":"Sheahan","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.neulet.2025.138154_b0170","doi-asserted-by":"crossref","first-page":"24328","DOI":"10.1074\/jbc.273.38.24328","article-title":"Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor\/G protein coupling","volume":"273","author":"Cheng","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2025.138154_b0175","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/mol.59.4.758","article-title":"Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors","volume":"59","author":"Cen","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2025.138154_b0180","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/acschemneuro.0c00407","article-title":"Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects","volume":"11","author":"Cao","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neulet.2025.138154_b0185","article-title":"Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neulet.2025.138154_b0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the kappa opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2025.138154_b0195","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4927","article-title":"In vivo brain GPCR signaling elucidated by phosphoproteomics","volume":"360","author":"Liu","year":"2018","journal-title":"Science"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:48:29Z","timestamp":1777553309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394025000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":39,"alternative-id":["S0304394025000424"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138154","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deletion of \u03b2-arrestin 2 in mice affects kappa opioid receptor-mediated behaviors depending on sex, ovariectomy status, and behavioral endpoints","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138154"}}